Title: Cross talk between RNA N6‐methyladenosine methyltransferase‐like 3 and miR‐186 regulates hepatoblastoma progression through Wnt/β‐catenin signalling pathway

Journal Article · · Cell Proliferation
DOI: https://doi.org/10.1111/cpr.12768 · OSTI ID:1593197
 [1];  [2];  [3];  [3];  [3];  [4];  [1];  [1];  [1]; ORCiD logo [3]
  1. Pediatric Surgery Department The First Affiliated Hospital of Zhengzhou University Zhengzhou China
  2. Endocrinology Department The First Affiliated Hospital of Zhengzhou University Zhengzhou China
  3. Precision Medicine Center The First Affiliated Hospital of Zhengzhou University Zhengzhou China
  4. Pathology Department The First Affiliated Hospital of Zhengzhou University Zhengzhou China

Abstract Objectives N6‐methyladenosine (m6A) is a ubiquitous epigenetic RNA modification that plays a pivotal role in tumour development and metastasis. In this study, we aimed to investigate the expression profiling, clinical significance, biological function and the regulation of m6A‐related genes in hepatoblastoma (HB). Materials and Methods The mRNA and protein expression levels of m6A‐related genes were analysed using Gene Expression Omnibus (GEO) and tissue microarray (TMA) cohort. Kaplan‐Meier analysis was performed to evaluate the prognostic value of m6A‐related genes in HB. Knockdown of m6A‐related genes was conducted to analyse its function on cell proliferation, migration and invasion. Furthermore, bioinformatics analysis and experimental verification were used to explore the potential molecular mechanism and signalling pathway. Results We found that most m6A‐related genes were significantly upregulated in HB tumour tissues. High levels of methyltransferase‐like 3 (METTL3, P  = .013), YTHDF2 ( P  = .037) and FTO ( P  = .032) indicated poor clinical outcomes, and the upregulation of METTL3 was an independent prognostic factor in HB patients. Functional assays showed that knockdown of METTL3 could dramatically suppress the proliferation, migration and invasion of HB cells. In addition, METTL3 was identified to be a direct target of microRNA‐186 (miR‐186). Consistently, miR‐186 was low expressed in HB tumour tissues. Moreover, overexpression of miR‐186 significantly inhibited cell aggressive phenotype both in vitro and in vivo, while the inhibitory effect could be reversed by METTL3 overexpression. Mechanism study indicated that miR‐186/METTL3 axis contributed to the progression of HB via the Wnt/β‐catenin signalling pathway. Conclusions M6A‐related genes were frequently dysregulated in HB. miR‐186/METTL3/Wnt/β‐catenin axis might serve as novel therapeutic targets and prognostic biomarkers in HB.

Sponsoring Organization:
USDOE
OSTI ID:
1593197
Journal Information:
Cell Proliferation, Journal Name: Cell Proliferation Journal Issue: 3 Vol. 53; ISSN 0960-7722
Publisher:
Wiley-BlackwellCopyright Statement
Country of Publication:
United Kingdom
Language:
English

References (42)

MicroRNA-492 is processed from the keratin 19 gene and up-regulated in metastatic hepatoblastoma journal February 2011
METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6 ‐methyladenosine‐dependent primary MicroRNA processing journal December 2016
RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2 journal April 2018
miR‐186 inhibits proliferation, migration, and epithelial‐mesenchymal transition in breast cancer cells by targeting Twist1 journal December 2018
Increased N6-methyladenosine causes infertility is associated with FTO expression journal March 2018
Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study journal September 2016
Caught up in a Wnt storm: Wnt signaling in cancer journal June 2003
Wnt signaling and hepatocarcinogenesis: The hepatoblastoma model journal February 2011
HBXIP-elevated methyltransferase METTL3 promotes the progression of breast cancer via inhibiting tumor suppressor let-7g journal February 2018
Dynamic RNA modifications in disease journal June 2014
Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability journal December 2011
The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells journal May 2016
m6A Facilitates eIF4F-Independent mRNA Translation journal November 2017
METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification journal February 2018
Nuclear m 6 A Reader YTHDC1 Regulates mRNA Splicing journal June 2016
N6-methyladenosine-dependent regulation of messenger RNA stability journal November 2013
N6-methyladenosine marks primary microRNAs for processing journal March 2015
The m6A methyltransferase METTL3 promotes bladder cancer progression via AFF4/NF-κB/MYC signaling network journal January 2019
Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism journal May 2018
METTL13 is downregulated in bladder carcinoma and suppresses cell proliferation, migration and invasion journal January 2016
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA journal March 2016
MeT-DB V2.0: elucidating context-specific functions of N6-methyl-adenosine methyltranscriptome journal November 2017
Management of hepatoblastoma: an update journal January 2014
MicroRNA-17, MicroRNA-19b, MicroRNA-146a, MicroRNA-302d Expressions in Hepatoblastoma and Clinical Importance journal January 2019
MicroRNA expression and its clinical implications in Ewing's sarcoma journal December 2014
miRNA-30e regulates abnormal differentiation of small intestinal epithelial cells in diabetic mice by downregulating Dll4 expression journal January 2016
Apoptosis induction in K562 human myelogenous leukaemia cells is connected to the modulation of Wnt/β-catenin signalling by BHX, a novel pyrazoline derivative journal January 2018
β-catenin regulates IRF3-mediated innate immune signalling in colorectal cancer journal July 2018
Effects of Wnt/β-catenin signalling on proliferation and differentiation of apical papilla stem cells: Effects of Wnt/β-catenin signalling journal January 2012
Natural Killer–Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms journal December 2018
MiR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1 journal August 2015
Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway journal September 2019
RUNX3 regulates hepatocellular carcinoma cell metastasis via targeting miR-186/E-cadherin/EMT pathway journal June 2017
Reduced m6A mRNA methylation is correlated with the progression of human cervical cancer journal October 2017
Oncogene c-Myc promotes epitranscriptome m6A reader YTHDF1 expression in colorectal cancer journal December 2017
Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential journal May 2016
Critical Enzymatic Functions of FTO in Obesity and Cancer journal July 2018
The Role of MicroRNAs in Hepatoblastoma Tumors journal March 2019
Long Noncoding RNA ANRIL Promotes Cervical Cancer Development by Acting as a Sponge of miR-186 journal April 2018
Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective journal February 2017
MicroRNA-186 suppresses cell proliferation and metastasis through targeting MAP3K2 in non-small cell lung cancer journal July 2016
MicroRNA-186 targets Yes-associated protein 1 to inhibit Hippo signaling and tumorigenesis in hepatocellular carcinoma journal March 2016